the bonfire

Once again Ole Gunnar Solskjær was able to draw a sigh of relief after winning a match that he “had to win”. The Guardian writer has a clear idea of ​​who Solskjær should use in midfield.

UNDER PRESS: Ole Gunnar Solskjær har tidligere vist at han takler det harde presset som Manchester United-manager. Foto: Martin Rickett / PA Photos
UNDER PRESSURE: Ole Gunnar Solskjær has previously shown that he can handle the hard pressure as Manchester United manager. Photo: Martin Rickett / PA Photos Show more


Several minutes of overtime saved Cristiano Ronaldo’s victory at Old Trafford. Ole Gunnar Solskjær’s men in the Champions League on Wednesday night.

Solskjær has recently again had to feel the pressure to have to deliver, and Wednesday’s victory was much needed for a Norwegian who had lost the two previous matches in the Premier League. – The difference between a draw and a win is heaven or hell. This provides peace for Solskjær. It’s much harder to argue against success, said Erik Thorstvedt in TV 2 studio.
MATCH WINNER: Cristiano Ronaldo secured the victory for Ole Gunnar Solskjær and co. Wednesday evening. Photo: REUTERS / Phil Noble Show more

– Expectation of success

Football Writer in The Guardian, Jonathan Wilson, has in a lengre article described why he thinks Wednesday’s victory was a small warning for Manchester United. – How much time can love buy you? That Manchester United supporters want Ole Gunnar Solskjær to succeed is indisputable. Not only did he score crucial goals, he legitimized a golden era. Who does not want a returning hero to lead the club back to the top again ?, he asks himself . – But hopeful thoughts will not organize a midfield, he continues.

ARREST THE JOURNALIST: Ole Gunnar Solskjær was as usual in a good and joking mood when he met the press. Video: Red Card. View more
Wednesday’s victory was a very small but important step on the way for Solskjær’s opportunity to take his first trophy as United manager.

– There is now an expectation of success, but it seems to be further away than ever, Wilson believes. Problem For a long time, one of the topics of discussion has been which midfielders Solskjær will put his trust in. With players like Paul Pogba, Bruno Fernandes, Donny van de Beek, Fred, Scott McTominay and Nemanja Matic, the Norwegian manager has a luxury problem.

DUO: Fred and Scott Mctominay are statistically a good choice for Solskjær in midfield. Photo: Reuters / Andrew Boyers Show more
But without the two midfielders, the winning percentage is 52% . The statistics Wilson refers to also show that they score significantly fewer goals per game (1.73) and concede significantly more goals (1.15) without the two together in the middle. Against Villarreal, the Red Devils were occasionally ravaged, but as so often before, United secured the victory shortly before the end. Wilson thinks it’s only a matter of time before the United team is punished more severely. Bone-tough program On Saturday, Everton awaits at home for Manchester United in the Premier League.

The team is in 4th place, only one point behind league leader Liverpool, but has so far had a simpler match program than the other title rivals. After the Everton match, four tough settlements await. Then Solskjær meets Leicester, Liverpool, Tottenham and Manchester City in a row.
Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Tourist washed away in Beas river near Manali, another missing thumbnail

Tourist washed away in Beas river near Manali, another missing

MANALI: Taking a selfie on the banks of Beas River near Manali in Himachal Pradesh's Kullu district proved fatal for a woman tourist from Madhya Pradesh, who slipped from the rock into the river, officials said on Sunday. The woman slipped from the rock near Nehru Kund, about 4 km from Manali, eyewitness said, adding
Read More
〈虎年景氣展望前瞻〉三家新藥臨床試驗入尾聲 年後解盲邁向新里程碑 thumbnail

〈虎年景氣展望前瞻〉三家新藥臨床試驗入尾聲 年後解盲邁向新里程碑

台睿、逸達、寶齡等三家新藥臨床試驗入尾聲。(圖:AFP)Tag台睿敗血症逸達新藥新冠新藥寶齡腎病拿百磷台灣生技廠新藥歷經多年開發,多項新藥臨床試驗預計農曆春節後公布結果,包括台睿 (6580-TW) 的敗血症用藥、逸達 (6576-TW) 旗下治療 COVID-19 重症 (重度症狀) 新冠新藥,以及寶齡富錦 (1760-TW) 腎病新藥拿百磷中國臨床試驗等都將進入尾聲,新藥解盲結果將為產業邁向另一里程碑。 台睿敗血症用藥 Rexis 三期臨床試驗,已於去年中完成 330 人收案,其合作的 7 家醫學中心同步整理臨床數據中,針對主要指標死亡率與次要指標副作用等進行分析,若解盲結果正向,預計 2023 年取得台灣藥證,並成為全球首個上市的抗敗血病新藥。 台睿除了搶攻台灣 12.6 萬名敗血症病患、逾 5 億元商機外,也將進軍美國市場,去年底向美國 FDA 提出臨床試驗申請,預計會從二期臨床試驗開始執行,擬採開放性試驗設計。 逸達新成分新藥 FP-025 用於治療 COVID-19 重症急性呼吸窘迫症候群 (ARDS) 第二 / 三期臨床試驗,為加速收案,除了持續在美國多個醫學中心進行外,去年第四季新增中南美洲、印度等受試基地,目標本季底完成招募 99 位受試者。 目前 ARDS 主要療法是透過呼吸器協助病患得到足夠氧氣,逸達指出,新冠新藥完成收案、病患服藥 28 天後可進行主要分析,病患的存活率與是否需要呼吸器成分析指標。 寶齡腎病新藥拿百磷已在台灣、美國、日本、歐洲等地區銷售,在中國執行的三期臨床試驗已於去年底完成,預計本季底前解盲,此外,寶齡中國合作夥伴山東威高為中國最大洗腎醫材供應商,市占率高達 9 成,若新藥順利解盲、取證,有望進一步挹注成長動能。 延伸閱讀台睿攜手共信開發抗癌新藥 放眼中國市場逸達氣喘新藥二期期中分析達標 明年中完成最終試驗逸達前列腺癌新劑型新藥 獲加拿大上市許可逸達新冠新藥臨床完成審查 明年首季完成收案台睿明年兩大產品有斬獲 敗血症新藥農曆年後解盲寶齡乾洗手產品未哄抬價格 經營秉持誠信原則特此澄清逸達前列腺癌新劑型新藥中國臨床進入審查 最快兩年完成寶齡快篩經台大醫院證實可偵測Omicron 準確率超過9成
Read More
Trump booed and heckled at Libertarian National Convention – video thumbnail

Trump booed and heckled at Libertarian National Convention – video

Donald Trump was booed and heckled during a raucous speech to the Libertarian National Convention as he appealed for them to vote for him. The Libertarian party, which prioritises small government and individual freedoms, typically gains 3% or less of the national vote but its members could yet prove crucial in swing states this November
Read More

Increase in the maximum amount of compensation the Agency can award for accessibility-related complaints

Since January 1st 2022, the maximum compensation for accessibility-related complaints has increased to $20,536.81. January 20 2022 – Gatineau, QC – Canadian Transportation Agency Since January 1st 2022, the maximum compensation for accessibility-related complaints has increased to $20,536.81. In the context of an accessibility complaint, the Canadian Transportation Agency (CTA) may award compensation for pain…
Read More
Index Of News
Total
0
Share